CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- S-1MEF Other S-1MEF
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 4 Option exercise Chief Commercial Officer acquired 209 shares (option exercise)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Option exercise Chief Financial Officer acquired 105 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 15,000 shares at $1.30 ($19,500)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Chief Commercial Officer acquired 208 shares (option exercise)
Page 4 of 46 · 907 filings